TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Europe Oral Rehydration Salt (ORS) Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.6 Potential Venture Avenues
4 Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast
4.2 tablets
4.3 Powder
4.4 Capsules
4.5 Others
5 Application Overview
5.1 Introduction
5.1.1 Market Size & Forecast
5.2 Diarrhoea
5.2.1 Child
5.2.2 Adult
5.4 Others
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast
6.2 Europe
6.2.1 Market Size & Forecast (Value)
6.2.2 Western Europe
6.2.2.1 Germany
6.2.2.1.1 By Type
6.2.2.1.2 By Application
6.2.2.2 France
6.2.2.2.1 By Type
6.2.2.2.2 By Application
6.2.2.3 U.K.
6.2.2.3.1 By Type
6.2.2.3.2 By Application
6.2.2.4 Italy
6.2.2.4.1 By Type
6.2.2.4.2 By Application
6.2.2.5 Spain
6.2.2.5.1 By Type
6.2.2.5.2 By Application
6.2.2.6 Rest of Western Europe
6.2.2.6.1 By Type
6.2.2.6.2 By Application
6.2.3 Eastern Europe
7. Company Profile
7.1 KBI Kunststoffbeutel Produktions GmbH & Co. KG
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 Monico SPA
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 Gebro Pharma AG
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 Primmed B.V.
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Nutriset
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 Clinova Ltd
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 Otsuka Pharmaceutical Co.,Ltd.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
